Addex Wins Michael J. Fox Foundation Funding To Take Its Dopamine Side Effect Therapy Into Phase II Testing
After a costly 2009 setback, venture philanthropy steps in to help Addex move a risky program forward.
After a costly 2009 setback, venture philanthropy steps in to help Addex move a risky program forward.